Traumatic Brain Injury

Overview

Team

Related Posts

More than 20 years ago, MRJ established our brain injury practice. Our team of attorneys and a medical researcher are devoted full time to litigating traumatic brain injuries. Our fluency in and understanding of both the science and the law applicable to brain injury claims enables us to leverage the technical and medical evidence underlying TBI diagnosis, pathophysiology, and outcome in every case.

 We have developed proven, strategic approaches to defending TBIs and their commonly alleged sequelae, such as post-traumatic stress disorder (PTSD), post-concussion syndrome (PCS), post-traumatic headaches, and post-traumatic vision syndrome. Central to these approaches is a detailed understanding of the underlying biology of TBI, the physics of neuroimaging techniques, and the methodology of neuropsychological testing.

Understand the science, and you will expose your opponent’s legal flaws.

We know concussion.

  • In-depth understanding of pathophysiology of mild TBI (including theories of neurometabolic cascade, neurotoxicity, and axonal shearing/diffuse axonal injury (DAI)).
  • Litigation and evaluation of TBI claims in more than 30 states.
  • Experience with claims by athletes and other individuals with repetitive-concussion history and accompanying expert opinions of injury vulnerability.
  • Experience litigating severe diagnoses, including DAI, chronic traumatic encephalopathy (CTE), and traumatically induced dementias, and forecasts of dire future consequences.
  • The science of brain injury is constantly evolving. We employ a full-time, in-house medical researcher dedicated to researching and updating the team on current and emerging medical literature.

 We know neuropsychology.

  • Extensive experience deposing neuropsychologists in their own language on their assessments of psychological and cognitive functioning, including issues with test battery selection, testing methodology, and data interpretation errors.
  • Successes compelling production by opponents’ experts of raw test data.
  • Internal library of neuropsychological test materials and track record of challenging experts who deviate from accepted methodology.
  • Well-versed on the strengths and weaknesses of specific neuropsychological tests.

We know advanced neuroimaging.

  • Numerous cases where “proof” of injury includes interpretations of diffusion tensor imaging (DTI), positron emission tomography (PET), single photon emission computed tomography (SPECT), quantitative electroencephalography (QEEG), and others.
  • Familiar with technical and physics underpinnings of all major neuroimaging techniques. Nuanced understanding of each technique’s administration protocol and technological limitations, including what imaging findings cannot tell you about injury timing and cause. Understanding based on current scientific literature of bounds of accepted use in diagnosis.
  • Depositions of neuroradiologists, nuclear medicine physicians, and neurologists aimed at evidentiary challenges

Related Posts

MRJ Attorneys Provide Guidance for Defense against Diffuse Axonal Injury Allegations

An article by MRJ attorneys Greg Kendall and Brandon Woodard entitled Defense Insights into Alleged Mild Diffuse Axonal Injuries was rece…

Read More

MRJ Attorneys Publish Article on PTSD in Aviation Cases

MRJ attorneys Kerry Mahedy, Brandon Woodard, and Greg Kendall co-authored an article providing an overview on defending PTSD claims in aviatio…

Read More

MRJ Attorneys Publish Truck EDR Evidence Primer

Brain Injury Team attorney Elaine Stoll and Brian Pokrywka, whose practice is focused on defending commercial vehicle transportation claims, &…

Read More

MRJ Brain Injury Team Attorneys to Present before Trucking Industry Defense Association

MRJ attorneys Brandon Woodard and Greg Kendall have been invited to speak this Friday at the Trucking Industry Defense Association’s (TI…

Read More

MRJ Brain Injury Team Attorneys Present at Cincinnati Bar Association

BRANDON WOODARD AND GREG KENDALL. On September 7, 2016, MRJ attorneys Brandon Woodard a…

Read More

Experimental Alzheimer’s Drug Shows Promise Early

A trial of an experimental drug for Alzheimer’s disease called aducanumab suggests the drug could be a b…

Read More

Study: Adult Brain Grows New Neurons, but at “Functionally Insignificant” Rate

A newly-published study has challenged the basis of a new and widely accepted theory in neuroscience. At issue…

Read More

New Brain Map Shows Twice as Many Functional Areas

A new map of the brain has been published which identifies many more distinct functional areas than were previously known. These functional ar…

Read More

Study Finds fMRI False Positive Rate Greatly Underestimated

New analysis of the software tools used to analyze functional magnetic resonance imaging (fMRI) data has discovered…

Read More

Study: MTBI has Elevated Effect on Academic Performance

Given that mild traumatic brain injuries (MTBI) are common among high school athletes, accounting for 13% of all injurie…

Read More